Indonesia Expat
Featured Sports/Health

Things You Should Know About the New Dengue Vaccine

Things You Should Know About the New Dengue Vaccine
Things You Should Know About the New Dengue Vaccine

Our team at Good Practice Clinic embraces this medical innovation and are enthusiastic about promoting it widely.

Every week, we diagnose at least one case of dengue infection. Only our patients can testify to the unpleasant symptoms and the anxiety of developing complications. Half of the world is now at risk due to climate change and urbanisation. One is more likely to get it in tropical countries, including Indonesia. Thankfully, Qdenga is now released as a vaccine against dengue.

What is dengue infection?

It is an infection caused by a virus transmitted through the bite of infected mosquitoes. Infected people are mostly without symptoms, but may develop a high fever (40C/104F), extreme body aches, and bleeding that require hospitalisation. Severe infection may cause death. There is no treatment; medications are mainly given to manage symptoms.

What is Qdenga?

Qdenga (TAK-003) is a vaccine that helps protect against dengue infection (serotypes 1, 2, 3, 4), produced by Takeda. It is a live attenuated vaccine, meaning it contains weakened parts of the dengue virus incapable of causing a disease. It is to trigger specific antibodies in your immune system and protect you from the real infection in the future. It is given in two doses (three-month gap).

Is it safe and effective?

It is approved for use in Indonesia, European countries and Brazil by the official health authorities. The efficacies: 80% in preventing fever, 90% in preventing hospitalisation, and 85.9% in preventing bleeding symptoms. (Interpretation: in 100 people who have been vaccinated twice, 80% are unlikely to develop a fever)

What if I’ve had dengue before?

It’s recommended regardless of previous dengue exposure. A person can get dengue infection more than once; the intensity of symptoms may vary.

Who can receive it?

Individuals 6 to 45 years old in Indonesia. Age groups may differ in other countries according to authorities.

Who should not receive it?

Known allergies to any active substance. Individuals with any immune deficiency (i.e. HIV/AIDS) or receiving chemotherapy/steroids. Women who are pregnant or breastfeeding.

What are the expected side effects?

The most common side effects are pain in the injected area, headache, body pain, tiredness, and fever. Occurs within 2 days after injection; mild to moderate in intensity; one to three days of duration.

How can I prevent getting dengue infection?

Wear clothes that cover as much of your body as possible. Use mosquito nets. Put on repellents (containing DEET/Picaridin/R3535, safe for children too). Use anti-dengue coils or vaporisers. Once a week, throw out or cover items that hold water (i.e. tyres, buckets, pools, birdbaths, flowerpots, trash containers).

Bottom line:

Our team at Good Practice Clinic embraces this medical innovation and are enthusiastic about promoting it widely. It’s important to discuss this with your doctor before deciding to receive this vaccine. We are open to receiving questions, so don’t hesitate to reach out.

It is important that you identify a clinic that you are comfortable with. GOOD PRACTICE has patients from 79 countries. Our English-speaking team implements international guidelines. We provide highly personalised care. Try us!

goodpractice.co.id

Related posts

Resolutions ? At Least Make it Interesting

Hush Petersen

The Art of Making Moke

Diana Subekti

Health Minister Comments on Potential for PPKM to be Revoked by August

Indonesia Expat

Indonesia and Singapore Interested in Training Polytechnic Lecturers

Indonesia Expat

Ramadan and “Being” Mode

Donny Syofyan

Latest PPKM Level 4 Restrictions

Indonesia Expat